跳至主要内容
临床试验/NCT05682209
NCT05682209已完成4 期

The Effect of Octreotide on the Duration of Post-mastectomy Wound Drainage: a Randomized Controlled Trial

Ikechukwu Bartholomew Ulasi1 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2020年12月18日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
41
试验地点
1
主要终点
Time to drain removal

研究概览

简要总结

Patients who had mastectomy for breast cancer usually have drainage of some fluid from the site of surgery. This could be prolonged and may lead to other negative consequences after surgery. Octreotide could potentially reduce the amount of this drainage. In this study, patients were grouped into two: a first group that received octreotide injection and a second group that received a placebo. The study tested whether octreotide injection has any effect on the duration of fluid drainage from the surgery site after mastectomy for breast cancer.

详细描述

Study design and location: This was a randomised controlled trial carried out at the University College Hospital Ibadan, a premier teaching hospital in South West Nigeria.

Study population: Study participants were recruited from female breast cancer patients who presented through the Surgery Out-Patient (SOP) clinic of the University College Hospital, Ibadan to these general surgical divisions over the study period.

Sample size determination: Assuming a standard normal deviate (Zα/2) at 5% type I error of 1.96, standard normal variate for power (Zβ, at 80% power) of 0.84, standard deviation of 1.9 to detect a difference in mean duration of drain of 1.7 days, and an attrition rate of 5%, a sample size formula for comparing 2 independent means was used to obtain a total sample size of 41 study participants.

Sampling and randomisation technique: Convenience sampling of breast cancer patients presenting during the study period was employed. Study participants were randomized into 2 groups, a treatment and a control group, using blocked sequence randomization. Consecutive female breast cancer patients were prospectively enrolled in turns into the two study groups via the surgical out-patient department of the University College Hospital, Ibadan over the study period till the required sample size was attained. A computer-generated blocked randomisation sequence was used to insert the instruction "1" or "2" (representing treatment or control groups respectively) consecutively to 30 serially numbered envelopes, all of which were sealed afterwards.

Data collection: Data was obtained through a detailed history and physical examination and includes sociodemographic variables like age, occupation, educational status, religion and tribe. Other pre-operative data obtained included BMI, diagnosis, clinical (TNM) stage, histology, tumor grade, comorbidities and ASA grade. Intra-operative data obtained included cadre of surgeon, length of skin incision, intra-operative blood loss, total number of lymph nodes removed, weight of mastectomy specimen and duration of surgery. Post-operatively, the daily volume of wound drainage, post-operative day of drain and suture removal, total drain volume, time to drain removal, occurrence of seroma formation, frequency and duration of seroma aspirations and total number of positive lymph nodes on histology were recorded. All the above data were entered into a questionnaire proforma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

性别
Female
接受健康志愿者

入选标准

  • All female breast cancer patients requiring modified radical mastectomy

排除标准

  • All mastectomies without axillary clearance (simple and toilet mastectomies)
  • Breast-conserving surgeries
  • Patients undergoing immediate breast reconstruction after mastectomy
  • Previous axillary surgery

研究组 & 干预措施

Octreotide group

Active Comparator

Received 100µg of octreotide intravenously 8-hourly for 5 days from the first post-operative day

干预措施: Octreotide Injection (Drug)

Control group

Placebo Comparator

Received 1ml of sterile water intravenously 8-hourly for 5 days from the first post-operative day

干预措施: Sterile water (Other)

结局指标

主要结局

Time to drain removal

时间窗: 24 hours after surgery till a drain output of <40ml in the preceding 24hours

Time that elapsed from the day of surgery till the wound drain was removed

次要结局

  • Incidence of seroma(From the first post-operative day till 28 days post-operatively)

研究者

发起方
Ikechukwu Bartholomew Ulasi
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ikechukwu Bartholomew Ulasi

Principal investigator

University College Hospital, Ibadan

研究点 (1)

Loading locations...

相似试验

Unknown
不适用
The Effect of Preoperative Long Period Octreotide Combined With Postoperative Short Period Octreotide on the Complications After Pancreatectomy. A Prospective, Multicenter Clinical TrialPancreatic Diseases
NCT03398941Chengfeng Wang150
Unknown
4 期
Effect of Ketalar to Prevent Postoperative Chronic Pain After MastectomyPainBreast Cancer
NCT00129597Hospices Civils de Lyon40
已完成
不适用
Adjuvant Radiotherapy's Effect on One and Two Stages Prosthetic Breast Reconstruction and on Autologous ReconstructionMammaplastyTransplant FailureBreast Implant ComplicationsComplications Radiotherapy
NCT04783818Humanitas Clinical and Research Center3,200
Unknown
不适用
Breast edema after breast-conserving surgery and radiotherapyIn contrast to arm morbidity which is thoroughly described in literature, only a few studies investigated breast morbidity after breast cancer treatment. Currently, there is no consensus on the definition of breast edema and on standardized assessment criteria. Common criteria found in literature are an increased volume of the breast, peau d’orange, heaviness of the breast, redness of the skin, breast pain, skin thickening, hyperpigmented skin pores and a positive pitting sign.
NL-OMON23137Faculty of Medicine and Health Sciences, department of rehabilitation sciences and physiotherapy, MOVANT research group, Universiteitsplein 1, 2610 Wilrijk, Belgium200
已完成
不适用
The Sequelae of Mastectomy and Quadrantectomy Respect to the Reaching Movement in Breast Cancer SurvivorsBreast CancerPain, ChronicPain, PostoperativeLymphedema Mastectomy
NCT04145739University of Roma La Sapienza65